P

Inventor

STAMOS DEAN

US45 patents
⚠️ This page may combine multiple inventors who share the name “STAMOS DEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERTEX PHARMA

28 patents
US6498178B2Dec 24, 2002

Inhibitors of IMPDH enzyme

VERTEX PHARMA174 citations97
US7872031B2Jan 18, 2011

c-MET protein kinase inhibitors

VERTEX PHARMA64 citations96
US6632809B2Oct 14, 2003

Gyrase inhibitors and uses thereof

VERTEX PHARMA63 citations96
US7846954B2Dec 7, 2010

Heterocyclic derivatives as modulators of ion channels

VERTEX PHARMA27 citations92
US7727992B2Jun 1, 2010

Gyrase inhibitors and uses thereof

VERTEX PHARMA23 citations92
US7582641B2Sep 1, 2009

Gyrase inhibitors and uses thereof

VERTEX PHARMA21 citations92
US7569591B2Aug 4, 2009

Gyrase inhibitors and uses thereof

VERTEX PHARMA27 citations92
US7528138B2May 5, 2009

Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

VERTEX PHARMA43 citations92
US7414046B2Aug 19, 2008

Gyrase inhibitors and uses thereof

VERTEX PHARMA35 citations92
USRE40245EApr 15, 2008

Gyrase inhibitors and uses thereof

VERTEX PHARMA36 citations92
US6608087B1Aug 19, 2003

Gyrase inhibitors and uses thereof

VERTEX PHARMA29 citations92
US7495014B2Feb 24, 2009

Gyrase inhibitors and uses thereof

VERTEX PHARMA25 citations91
US7087642B2Aug 8, 2006

Inhibitors of IMPDH enzyme

VERTEX PHARMA13 citations91
US8034832B2Oct 11, 2011

Gyrase inhibitors and uses thereof

VERTEX PHARMA13 citations83
US7998987B2Aug 16, 2011

Inhibitors of c-Met and uses thereof

VERTEX PHARMA8 citations83
US7728017B2Jun 1, 2010

Inhibitors of c-Met and uses thereof

VERTEX PHARMA8 citations83
US7799822B2Sep 21, 2010

Phenyl sulfonamides as modulators of ion channels

VERTEX PHARMA8 citations82
US7432290B2Oct 7, 2008

Inhibitors of IMPDH enzyme

VERTEX PHARMA6 citations74
US12247021B2Mar 11, 2025

Substituted tetrahydrofurans as modulators of sodium channels

VERTEX PHARMA1 citations72
US11834441B2Dec 5, 2023

Substituted tetrahydrofurans as modulators of sodium channels

VERTEX PHARMA4 citations72
US11919887B2Mar 5, 2024

Substituted tetrahydrofurans as modulators of sodium channels

VERTEX PHARMA2 citations71
US11827627B2Nov 28, 2023

N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

VERTEX PHARMA3 citations71
US8343763B2Jan 1, 2013

Heterocyclic derivatives as modulators of ion channels

VERTEX PHARMA2 citations62
US7994166B2Aug 9, 2011

Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain

VERTEX PHARMA4 citations62
US12258333B2Mar 25, 2025

N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

VERTEX PHARMA0 citations60
US8841282B2Sep 23, 2014

Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels

VERTEX PHARMA0 citations51
US8586589B2Nov 19, 2013

Piperidine and piperazine phenyl sulfonamides as modulators of ion channels

VERTEX PHARMA0 citations51
US6930116B2Aug 16, 2005

Gyrase inhibitors and uses thereof

VERTEX PHARMA1 citations51

CHARIFSON PAUL

5 patents

VIVIDION THERAPEUTICS INC

3 patents

STAMOS DEAN

2 patents

LAUFFER DAVID J

1 patent

CHARIFSON PAUL S

1 patent

MARTINBOROUGH ESTHER

1 patent

HILGRAF NICOLE

1 patent

MARTINBOROUGH ESTHER ANN

1 patent

BINCH HAYLEY

1 patent

ARONOV ALEXANDER

1 patent